ArticleBlood cancer journal2024

Quadruplet therapy for newly diagnosed myeloma: comparative analysis of sequential cohorts with triplet therapy lenalidomide, bortezomib and dexamethasone (RVd) versus daratumamab with RVD (DRVd) in transplant-eligible patients.

Nisha S Joseph et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.